PharmaRoth Labs, Inc.
ROTH
$0.00
$0.000.00%
OTC PK
| 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 17,770.00% | 2,588.89% | 1,700.00% | 55.17% | 1,100.00% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 29,740.00% | 2,588.89% | 1,700.00% | 55.17% | 1,100.00% |
| Operating Income | -9,720.00% | -2,588.89% | -1,700.00% | -55.17% | -1,100.00% |
| Income Before Tax | -9,980.00% | -2,911.11% | -1,700.00% | -8,675.86% | -1,100.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -9,980.00% | -2,911.11% | -1,700.00% | -8,675.86% | -1,100.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -9,980.00% | -2,911.11% | -1,700.00% | -8,675.86% | -1,100.00% |
| EBIT | -9,720.00% | -2,588.89% | -1,700.00% | -55.17% | -1,100.00% |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -- | -- | -1,600.00% | -- | -- |
| Normalized Basic EPS | -- | -- | -1,000.00% | -- | -- |
| EPS Diluted | -- | -- | -1,600.00% | -- | -- |
| Normalized Diluted EPS | -- | -- | -1,000.00% | -- | -- |
| Average Basic Shares Outstanding | 8.05% | 0.00% | 0.37% | 0.00% | 0.00% |
| Average Diluted Shares Outstanding | 8.05% | 0.00% | 0.37% | 0.00% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |